Itau Unibanco Holding S.A.’s Integra LifeSciences IART Stock Holding History

Itau Unibanco Holding S.A.’s Portfolio IART Stock Details IART Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q1	–	Sell	-96	Closed	-$4.18K	–	233
2023 Q4	$4.18K	Sell	96 -24	-20%	-$944	﹤0.01%	352
2023 Q3	$4.58K	Sell	120 -626	-84%	-$26.3K	﹤0.01%	450
2023 Q2	$30.7K	Buy	746 +615	+469%	+$29.6K	﹤0.01%	374
2023 Q1	$7.52K	Hold	131	–	–	﹤0.01%	465
2022 Q4	$7.34K	Sell	131 -10	-7%	-$509	﹤0.01%	475
2022 Q3	$6K	Hold	141	–	–	﹤0.01%	512
2022 Q2	$8K	Sell	141 -112	-44%	-$6.73K	﹤0.01%	432
2022 Q1	$16K	Buy	253 +10	+4%	+$658	﹤0.01%	398
2021 Q4	$17K	Buy	243 +40	+20%	+$2.71K	﹤0.01%	374
2021 Q3	$14K	Buy	203 +5	+3%	+$353	﹤0.01%	353
2021 Q2	$14K	Buy	+198	New	+$14K	﹤0.01%	323
2020 Q1	–	Sell	-194	Closed	-$11K	–	613
2019 Q4	$11K	Buy	+194	New	+$11.5K	﹤0.01%	846

Other funds holding IART

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

AllianceBernstein Nashville, Tennessee $309B AUM 23.92% 1-Year Est. Return

Cooke & Bieler Philadelphia, Pennsylvania $8.84B AUM 6.92% 1-Year Est. Return

CIP

Champlain Investment Partners Burlington, Vermont $7.88B AUM 6.82% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

Itau Unibanco Holding S.A.'s IART Position: Q1 2024 in Review

Itau Unibanco Holding S.A. sold out of Integra LifeSciences (IART) in Q1 2024, closing a stake of 96 shares — an estimated $4.18K sold.

Itau Unibanco Holding S.A. first reported a position in IART in Q4 2019 and held it in 12 quarters. The position peaked at $30.7K in Q2 2023. 281 funds tracked by Wall St. Rank hold IART as of Q1 2024.

Itau Unibanco Holding S.A. reported no remaining Integra LifeSciences position as of Q1 2024 after selling out during the quarter.
Itau Unibanco Holding S.A. sold 96 Integra LifeSciences shares in Q1 2024, an estimated $4.18K.
Itau Unibanco Holding S.A. first reported a position in Integra LifeSciences in Q4 2019 and held it in 12 quarters.
Itau Unibanco Holding S.A.'s Integra LifeSciences position peaked at $30.7K in Q2 2023.
281 funds tracked by Wall St. Rank held Integra LifeSciences as of Q1 2024.

Based on Itau Unibanco Holding S.A.'s 13F filing for Q1 2024, filed 14 May 2024.